An important segment of India’s business community woke up Wednesday to a fright: President Trump had again brandished the threat of tariffs on pharmaceutical imports.

       “We’re going to be announcing very shortly a major tariff on pharmaceuticals,” he told guests at a dinner held by the National Republican Congressional Committee.

       India has spent most of a week trying to find reasons for hope after the shock of being hit with a 27 percent blanket rate. One of the best was the fact that the global pharmaceutical industry was excluded from the first round of tariffs.

       Subscribe to The Times to read as many articles as you like.